These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16078963)

  • 1. The cost effect of newer medication adoption in an older Medicaid cohort.
    Shireman TI; Rigler SK; Jachna CM; Griebling TL; Eng ML
    J Am Geriatr Soc; 2005 Aug; 53(8):1366-73. PubMed ID: 16078963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.
    Chu L; Schnelle JF; Osterweil D
    J Am Med Dir Assoc; 2004; 5(2):75-81. PubMed ID: 14984617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
    Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
    Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009.
    Gorevski E; Bian B; Kelton CM; Martin Boone JE; Guo JJ
    Ann Pharmacother; 2012 Apr; 46(4):503-12. PubMed ID: 22454448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of potentially inappropriate medication use across three cohorts of older Medicaid recipients.
    Rigler SK; Jachna CM; Perera S; Shireman TI; Eng ML
    Ann Pharmacother; 2005; 39(7-8):1175-81. PubMed ID: 15928259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients.
    Smalley WE; Griffin MR; Fought RL; Sullivan L; Ray WA
    N Engl J Med; 1995 Jun; 332(24):1612-7. PubMed ID: 7753141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in drug use and expenditures in a privately insured population of older adults.
    Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
    J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.